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Conjugated N-glycans are considered next-generation bioactive prebiotic compounds
due to their selective stimulation of beneﬁcial microbes. These compounds are
glycosidically attached to proteins through N-acetylglucosamines via speciﬁc
asparagine residue (AsN-X-Ser/Thr). Certain bacteria such as Biﬁdobacterium longum
subspecies infantis (B. infantis) have been shown to be capable of utilizing conjugated
N-glycans, owing to their specialized genomic abilities. B. infantis possess a unique
enzyme, Endo-ß-N-acetylglucosaminidase (EndoBI-1), which cleaves all types of
conjugated N-glycans from glycoproteins. In this study, recombinantly cloned EndoBI1 enzyme activity was investigated using various immobilization methods: 1) adsorption, 2)
entrapment-based alginate immobilization, 3) SulfoLink-, and 4) AminoLink-based
covalent bonding immobilization techniques were compared to develop the optimum
application of EndoBI-1 to food processes. The yield of enzyme immobilization and the
activity of each immobilized enzyme by different approaches were investigated. The
N-glycans released from lactoperoxidase (LPO) using different immobilized enzyme
forms were characterized using MALDI-TOF mass spectrometry (MS). As expected,
regardless of the techniques, the enzyme activity decreased after the immobilization
methods. The enzyme activity of adsorption and entrapment-based alginate
immobilization was found to be 71.55% ± 0.6 and 20.32% ± 3.18, respectively,
whereas the activity of AminoLink- and SulfoLink-based covalent bonding
immobilization was found to be 58.05 ± 1.98 and 47.49% ± 0.30 compared to the
free form of the enzyme, respectively. However, extended incubation time recovery
achieved activity similar to that of the free form. More importantly, each immobilization
method resulted in the same glycan proﬁle containing 11 different N-glycan structures from
a model glycoprotein LPO based on MALDI-TOF MS analysis. The glycan data analysis
suggests that immobilization of EndoBI-1 is not affecting the enzyme speciﬁcity, which
enables full glycan release without a limitation. Hence, different immobilization methods
investigated in this study can be chosen for effective enzyme immobilization to obtain
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bioactive glycans. These ﬁndings highlight that further optimization of these methods can
be a promising approach for future processing scale-up and commercialization of EndoBI1 and similar enzymes.
Keywords: B. infantis, Endo-ß-N-acetylglucosaminidase, N-glycans, immobilization, bioactive compounds

1 INTRODUCTION

is that they are fermented to short-chain fatty acids (SCFAs) such
as acetate and lactate, which creates an unfavorable environment
for the growth of pathogens. Consequently, bioactive N-glycans
provide colonization resistance to pathogens and reduce
inﬂammation as well as virulence factors (Duar et al., 2020).
The release of N-glycans from glycoproteins is a crucial step in
both experimentally determining biological characteristics and
the large-scale production of these bioactive molecules (Helenius,
2001). N-glycans can be released from glycoproteins using
different chemical and enzymatic treatments, but the current
deglycosylation methods require harsh treatment and extreme
reaction conditions such as pH or temperature (Karav et al.,
2017). Although chemical treatments including beta-elimination,
hydrazinolysis, and triﬂuoromethanesulfonic acid are considered
as easy-to-use, low cost, and rapid, they can degrade the glycan
structures, limiting further analysis of these glycans (Tams and
Welinder, 1998; Nakakita et al., 2007; Zauner et al., 2012).
Peptide-N4-(N-acetyl-b-D-glucosaminyl) asparagine amidases
(PNGases) is a type of glycosidase, a group of enzymes
commonly used for releasing N-glycans from glycoprotein
moieties (Takahashi, 1977; Nuck et al., 1990). Similar to
chemical methods, enzymatic deglycosylation treatments also
have various limitations. To increase the enzyme accessibility
to the glycans, the enzymatic reaction with PNGases requires high
temperatures and different detergents for the deglycosylation
process. This might result in the degradation of the intact
form of glycans and remaining polypeptide chains (Tarentino
and Plummer, 1994; Fryksdale et al., 2002). While other
commercial endoglycosidases such as endoglycosidases H
(Endo H) and endoglycosidases F1, F2, and F3 (Endo F1, F2,
and F3) show more activity for the deglycosylation of native
glycans from glycoproteins when compared to PNGases, these
endoglycosidases show low activity on the deglycosylation of
multiple-antennary types N-glycans (Trimble and Tarentino,
1991; Garrido et al., 2012). Therefore, the development of an
effective deglycosylation method for releasing N-glycans without
any degradation of their intact form is warranted (Karav, 2019;
Sucu et al., 2021). Endo-β-N-acetylglucosaminidase (EndoBI-1) is
a novel enzyme that is recently isolated from Biﬁdobacterium
longum subspecies infantis (B. infantis) ATCC 15697 (Garrido
et al., 2012; Karav et al., 2015b). This novel enzyme cleaves
N-N’diacetyl chitobiose moiety found in all types of N-glycans,
and core fucosylation has no effect on the enzyme activity. It is
also considered as heat resistant and shows activity during 95°C
heat treatments (Karav et al., 2015a; Karav et al., 2015b; Parc et al.,
2015). These properties make EndoBI-1 ideal for several
applications, especially for the food industry (Karav et al.,
2015b; Parc et al., 2015; Şahutoğlu et al., 2020; Duman et al., 2021).
Enzymes can be unsuitable for direct application to different
industrial processes because of their biological origin, activity,

Bioactive compounds are deﬁned as nutrient or non-nutrient
substances which can have physiological, behavioral, and
immunological effects (Biesalski et al., 2009). These
compounds are extensively studied to reveal their potential
antioxidant, anti-inﬂammatory, and antimicrobial activities
with various in vitro and in vivo studies. Bioactive compounds
are derived from both plant sources, including phenolics and
carotenoids, and animal sources containing milk peptide and
fatty acids (Patil et al., 2009; Arslan et al., 2021). Novel bioactive
compounds are used in the ﬁelds of functional foods,
pharmaceuticals, nutrition, biotechnology, and agriculture,
which results in increased numbers of nutritional products
with a myriad of health beneﬁts (Biesalski et al., 2009; Kaplan
et al., 2022). To date, N-glycans are regarded as a bioactive
compound with scientiﬁc and technological developments
(Karav et al., 2015b; Karav, 2018). In nature, glycans are
oligosaccharides that can be covalently attached to protein
structures by O-glycosidic or N-glycosidic bonds (Stanley
et al., 2009). O-linked glycans (O-glycans) are mostly linked to
a polypeptide chain at a serine/threonine residue and can be
extended into several core classes, while N-linked glycans
(N-glycans) are linked through N-acetylglucosamines
(HexNAc) to a speciﬁc asparagine residue (AsN-X-Ser/Thr).
The N-glycan core consists of two HexNAc residues followed
by three mannoses, and the N-glycan types are determined
through further glycosylation with other monosaccharides.
N-glycans are basically classiﬁed into three main classes
including high mannose (HM), complex type (CT), and
hybrid (HY) based on the degree of branching and the type of
linkages (Ohtsubo and Marth, 2006; Stanley et al., 2009). As with
the other important macromolecules, N-glycans are one of the
most signiﬁcant bioactive compounds that show a variety of
biological activities including cell adhesion and mobility, receptor
activation, protein folding and degradation, immune signaling,
and protection against pathogens (Barboza et al., 2012; Duman
et al., 2021). In addition, N-glycans have prebiotic properties
since they are indigestible by human digestive enzymes, which
means they can reach the colon intact and be utilized by certain
bacterial species found in the gut microbiota. Thus, these
compounds can serve as novel prebiotic substrates that can
selectively stimulate the growth of speciﬁc beneﬁcial bacteria
such as Biﬁdobacteria (Koropatkin et al., 2012; Karav et al.,
2019). Furthermore, as N-glycans are similar to human milk
oligosaccharides (HMOs) in terms of the monosaccharide
composition and linkage, they are proposed to have a
biﬁdogenic effect (Karav et al., 2016). These bioactive
compounds enhance the growth of Biﬁdobacteria and in turn
shape the gut microbiota. Another noticeable effect of N-glycans
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and different reaction conditions including pH and temperature.
(Yamaguchi et al., 2020). In such cases, they have limited stability,
and also do not possess an optimum catalytic feature. Thus,
different immobilization approaches can help overcome these
drawbacks (Garcia-Galan et al., 2011; Sheldon and van Pelt, 2013;
Yamaguchi et al., 2020). In general, the process of immobilization
is the attachment or adsorption of a soluble enzyme to solid
support, the entrapment in a matrix, or the aggregation of the
enzyme, allowing enzyme reuse during production (Cao et al.,
2003; Datta et al., 2013). Several enzyme immobilization methods
have been improved and used since Nelson and Grifﬁn in 1916.
Enzyme immobilization methods can be classiﬁed as reversible
immobilization and irreversible immobilization methods. While
the reversible immobilization method is further grouped as
adsorption, ionic binding, afﬁnity binding, and metal binding,
the irreversible immobilization method is grouped as covalent
bonding, entrapment, and aggregation (Karav et al., 2017).
Generally, immobilization techniques can have some
drawbacks. For example, reversible immobilization techniques
can cause enzyme leaching that prevents enzyme reusability or
irreversible enzyme immobilization may minimize enzyme
activity because of the active site blockage and inherent
diffusion problems (Karav et al., 2017). Thus, the optimal
immobilization method for the enzyme is determined
according to the physicochemical properties of the enzyme,
support material, and substrate matrix that are used in the
immobilization process (Nisha et al., 2012).
In this study, different types of immobilization strategies
including adsorption, entrapment, and covalent bonding such
as AminoLink- and SulfoLink-based covalent bonding methods
were evaluated for the potential application of EndoBI-1 in the
food industry in terms of enzyme activity and speciﬁcity.

FIGURE 1 | Representation of adsorption- and entrapment-based
immobilization methods. In the adsorption-based immobilization method, the
soluble enzyme attaches to solid support, whereas the soluble enzyme is
entrapped in a support material in the entrapment-based immobilization
method.

expression and puriﬁcation. The vector was transformed into
Escherichia cloni (E. cloni) 10G chemically competent cells
(Lucigen Corp.). After the conﬁrmation of positive clones using
Colony PCR, E. cloni 10G cells containing the vector were
incubated at 37°C, and 2.5–3 h (h) duration to reach the optical
density at 600 nm of ~0.6. Protein expression was induced by the
addition of rhamnose solution (0.2% ﬁnal concentration). The
enzyme was puriﬁed after the bacterial lysis process using afﬁnity
chromatography with the Ni-charged columns (Bio-Rad, Hercules,
CA, United States). The expression and purity of the enzyme were
conﬁrmed by 12–4% SDS-PAGE gel electrophoresis. The
recombinantly produced EndoBI-1 was kept at −80°C for
further analysis (Supplemental Figure S1, S2).

2 MATERIALS AND METHODS
2.1 Reagents, Enzymes, and Substrates

™

™

2.3 Enzyme Immobilization

The Sulfolink Immobilization Kit (44995), the AminoLink
Immobilization Kit (44890), and Qubit Protein Assay Kit
(Q33211) were purchased from Thermo Fisher Scientiﬁc
(Waltham, MA Unites States). Calcium chloride (CaCl2),
sodium alginate (Na-alginate), sodium chloride (NaCl),
sodium phosphate dibasic dihydrate (Na2HPO4·2H2O), sodium
phosphate monobasic (NaH2PO4), and lactoperoxidase (LPO)
from bovine milk were obtained from Sigma Aldrich Chemical
Co. (St Louis, Missouri, United States).

™

2.3.1 Enzyme Immobilization by Adsorption Method
For the immobilization of EndoBI-1 using the adsorption
method, Na-alginate was selected as a support material
(Figure 1). To achieve the highest immobilization efﬁciency,
different pH levels of sodium acetate solution were used
during the immobilization process. A total of 1 g of Naalginate powder was dissolved in 50 ml of dH2O to prepare
2% Na-alginate solution, and 1.25 g of CaCl2 powder was
dissolved in 25 ml of dH2O to prepare 5% CaCl2 buffer
solution. The Na-alginate solution was then dripped into a 5%
CaCl2 solution through a G22 syringe to form alginate beads. The
alginate beads were ﬁltered through ﬁlter paper and washed with
dH2O. For the enzyme adsorption, 0.1 M sodium acetate
solutions at different pH (6.34, 4.83, and 3.63) were mixed
with EndoBI-1 (1.88 mg/ml) and alginate beads were added to
each treatment while mixing. Each mixture was stirred for
1–1.30 h. The concentration of alginate-bound and unbound
enzyme was determined ﬂuorometrically two times using the
Qubit protein assay kit.

2.2 Recombinant Enzyme Production
An Expresso® Rhamnose Cloning & Protein Expression in

vivo
cloning system (Lucigen Corp., Middleton, WI, United States) was
preferred for gene cloning, and the manufacturer’s protocols were
followed. The coding sequence of EndoBI-1 (Blon_2468) was
ampliﬁed from B. infantis ATCC 15697 genomic DNA using
appropriate cloning primers and then cloned into the pRham
N-His Kan vector. The enzyme was cloned by adding an
N-terminal poly-histidine tag (His-tag) without transmembrane
domains and signal peptide sequences to facilitate protein

™
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FIGURE 2 | Representation of general structure and reaction scheme for the SulfoLink (A) and AminoLink coupling resin (B).

2.3.2 Enzyme Immobilization by Entrapment Method
For the immobilization of EndoBI-1 using the entrapment
method, Na-alginate was used as a support material
(Figure 1). The alginate bead concentration is the most
important criteria for the entrapment type immobilization;
therefore, different concentrations of Na-alginate solution (2%,
3%, and 4%) were used to investigate the immobilization
efﬁciency. First, EndoBI-1 (1.88 mg/ml) was added into each
Na-alginate solution. The mixtures obtained were extruded
dropwise using a G22 syringe, into a gently stirred 5% CaCl2
solution. The formed beads were left in the CaCl2 solution with a
stirrer for about 10 min (min). After washing with dH2O of beads,
the Qubit assay kit was used for the measurement of
nonentrapped and entrapped enzyme concentrations. The
measurement was performed two times.

containing enzyme solution was transferred to the SulfoLink column,
and the column was incubated at room temperature for 15 min with
end-over-end mixing and then for 30 min without mixing. After
incubation, the SulfoLink column was placed into a new tube and
centrifuged at 1,000 x g for 1 min at 25°C to collect nonbound
enzyme. Finally, the column was rinsed with wash solution and was
then stored at 4°C based on the manufacturer’s protocol. Immobilized
enzyme concentration was measured two times using the Qubit
protein assay kit.

2.3.4 Enzyme Immobilization by AminoLink Covalent
Bonding Method
EndoBI-1 was immobilized on the AminoLink coupling resin using
the AminoLink Plus Immobilization Trial Kit (Thermo Scientiﬁc)
according to the manufacturer’s directions (Figure 2). For
AminoLink-based immobilization, the coupling buffer solution
and storage buffer solution were prepared according to the
manufacturer’s instructions using the kit contents. To prepare the
enzyme solution, 4 ml of pH 10.0 coupling buffer solution was mixed
with 1 ml of enzyme solution (1.88 mg/ml) completely. The
AminoLink plus resin was suspended by end-over-end mixing,
and the column was centrifuged in a 15 ml falcon tube at 1,000 x
g for 1 min at 24°C to remove the storage buffer. A total of 2 ml of
pH 10.0 coupling buffer was added into the column, and the column
was then centrifuged at 1,000 x g for 1 min at 24°C. After this process
was applied one more time, the enzyme solution was injected into
the column containing the compact resin bed, and 0.1 ml of coupling
buffer was added into the column. A total of 0.1 ml of the sample was
stored at 4°C for the measurement of coupling efﬁciency later. After
this, the column was incubated for 2 h by end-over-end rocking and
incubated for 2 h while kept upright without mixing at room
temperature. After incubation, the caps of the column were
removed and placed into a new tube. To collect nonbound
enzymes, centrifugation was carried out at 1,000 x g for 1 min at
24°C. The column was washed with 2 ml of pH 7.2 phosphatebuffered saline (PBS) solution and centrifuged. A total of 2 ml of
pH 7.2 coupling buffer was mixed with 40 μL of sodium

2.3.3 Enzyme Immobilization by SulfoLink Covalent
Bonding Method
EndoBI-1 was immobilized on the SulfoLink coupling resin
employing the SulfoLink Immobilization Trial Kit (Thermo
Scientiﬁc), following the manufacturer’s directions (Figure 2). To
prepare the enzyme for coupling, 1.88 mg/ml of EndoBI-1 was
dissolved in 1 ml of sample preparation buffer, and the enzyme
solution was transferred to the vial containing 6 mg of 2mercaptoethylamine•HCl (2-MEA) (50 mM) and incubated for
1.5 h at 37°C. The desalt spin column which is provided with the
kit was equilibrated using the coupling buffer and centrifuged at
1,000 x g for 1 min at 25°C. After this process was applied one more
time, the enzyme solution was injected into the column containing
the compact resin bed, and 0.1 ml of coupling buffer was added into
the column. The reduced enzyme was collected after centrifugation at
1,000 x g for 1 min at 25°C for later determining coupling efﬁciency.
For SulfoLink-based immobilization, SulfoLink resin was suspended
gently by end-over-end mixing and centrifuged at 1,000 x g for 1 min
at 25°C to remove the storage buffer from the column. A total of 2 ml
of coupling buffer was added into the column, and the centrifugation
process was applied at 1,000 x g for 1 min at 25°C. The sulfhydryl-
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cyanoborohydride solution, and then the resulting solution was
transferred to the column. Incubation at room temperature was
conducted for the column by mixing for 4 h. Finally, the column was
stored at 4°C according to the manufacturer’s directions.
Immobilized
enzyme
concentration
was
measured
ﬂuorometrically two times using the Qubit protein assay kit.

acetonitrile (ACN) to reach an optimal loading solution. The cottoncontaining pipette tip was washed sequentially with 100 μL of dH2O
and 100 μL of 85% ACN. The loading solution was then passed
through the cotton-containing pipette tip at least 20 times. After that,
the pipette tip was washed three times with ACN/dH2O/
triﬂuoroacetic acid (TCA) solution (85/14/1 v/v/v), followed by
85% ACN to completely purify N-glycans from salt and other
solvent residues. Elution was performed with 20 μL of dH2O
prior to mass spectrometry analysis. A total of 1 μL of elution
solution was dropped onto the MTP 384 anchor plate and dried.
A total of 1 μL of DHB matrix (2-5 dihydroxy benzoic acid) prepared
in ACN/dH2O (1:1 v/v) was then added to this spot. After
crystallization, the analysis was performed by collecting at least
8,000 laser shots in reﬂectron mode in negative ionization. The
Bruker RapiﬂeX MALDI Tissuetyper MS was calibrated with a
peptide mixture by applying 25 kV acceleration voltage, and mass
spectra were acquired in the 1,000–4,000 mass range. The released
N-glycan peaks obtained from MALDI-MS analysis were annotated
by matching the theoretically obtained 2-AA–labeled N-glycan mass
peaks that were generated by GlycoWorkbench software.

2.4 Determination of Kinetic Parameters
Using Lactoperoxidase
The kinetic parameters (Km and Vmax) of free and immobilized
EndoBI-1 by each method (adsorption, entrapment, SulfoLink-, and
AminoLink-based covalent bonding) were evaluated by the
measurement of enzyme activity on LPO as a substrate. The
concentration of released glycans was determined using the
phenol-sulfuric acid assay, calorimetrically. The kinetic parameters
of free and immobilized EndoBI-1 were calculated using GraphPad
Prism 9.0 (GraphPad Software Inc., San Diego). Data were analyzed
and plotted by ﬁtting to linear regression analysis (Lineweaver Burk)
with the initial rates at different substrate concentrations (0.1–0.8 mg/
ml and the incubation time of 20 min) based on the
Michaelis–Menten equation. The kinetic parameters of free and
immobilized EndoBI-1 were determined two times, and one-way
ANOVA variance analysis along with Tukey’s multiple comparisons
statistical test was performed to assess the statistical signiﬁcance of the
data at p < 0.05 using NCSS 12 statistical software.

3 RESULTS
3.1 Enzyme Immobilization Yield
The enzyme immobilization yield of SulfoLink- and AminoLinkbased covalent bonding, adsorption, and entrapmentimmobilized EndoBI-1 was determined by quantifying the
total protein and remaining unbound protein after the
washing process. The enzyme immobilization yield was
calculated using the following equation:

2.5 Characterization of Released N-Glycans
Using Matrix-Assisted Laser
Desorption-Ionization-Time of Flight Mass
Spectrometry

Immobilization Yield (%) 

2.5.1 Deglycosylation of Lactoperoxidase
To characterize the released N-glycans from LPO, ﬁrst, 5 mg/ml
LPO was deglycosylated using free and immobilized forms of
EndoBI-1 enzyme (0.025 mg/ml) in 0.02 M Na2HPO4 buffer
solution under optimized conditions (37°C, pH 5, and
overnight). After the reaction was terminated and the released
glycans were collected by protein precipitation using cold ethanol
into the sample (4:1 v/v), and the substrate and enzyme
concentrations were determined using the Qubit protein assay
kit based on the manufacturer’s instructions.

where Pt is the concentration of total protein and Pu is the
remaining unbound protein concentration. All the measurements
were carried out ﬂuorometrically in triplicate by using the Qubit
protein assay kit. The results of the ﬂuorescence method
demonstrated the high immobilization yield (87.41%) of the
AminoLink-based covalent bonding method, whereas the
SulfoLink-based covalent method immobilized 80.41% of the
enzyme. Immobilization with the adsorption method resulted
in the lowest immobilization yield. To investigate the highest
immobilization efﬁciency, different pH levels of sodium acetate
solution were tested during the immobilization process.
Accordingly, the adsorption yield was found to be 4.28% at
6.34 pH, 15.83% at 4.83 pH, and 41.72% at 3.63 pH. The
immobilization yield of the entrapment method was found to
be 15.43, 63.83, and 79.26% for the different alginate bead
concentrations (2, 3, and 4%, respectively) (Figure 3).

2.5.2 Characterization of N-Glycans
After enzymatic digestion and protein precipitation, N-glycans were
characterized using a RapiﬂeX MALDI Tissuetyper MS (Bruker
Daltonics, Bremen, GmbH). The N-glycans released using different
EndoBI-1 containing materials were labeled with 2-aminobenzoic
acid (2-AA) as described previously with minor modiﬁcations
(Ruhaak et al., 2008). A total of 50 μL of released N-glycan
samples were mixed with 25 μL of 2-AA [48 mg/ml containing
15% (v/v) acetic acid in dimethyl sulfoxide (DMSO)] and 25 μL of 2picoline-borane (Pic-BH3; 107 mg/ml in DMSO). The reaction
solution was then incubated at 65°C for 2 h. After the labeling
process, a cotton-containing pipette tip was used for the puriﬁcation
of N-glycans. The cotton ﬁbers were placed on a 100-µL pipette
tip. The 2-AA labeled samples (25 μL) were mixed with 140 μL of
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x 100,
Pt

3.2 Kinetic Characterization Using
Lactoperoxidase
Kinetic parameters of the free and immobilized EndoBI-1 enzyme
on LPO with different techniques were determined according to
the Michaelis–Menten model. First, preliminary trials were
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FIGURE 3 | Protein immobilization yield for adsorption- (A), entrapment- (B), AminoLink- (C), and SulfoLink-based (C) immobilization methods, measured
ﬂuorometrically by the Qubit Protein Assay Kit. Error bars represent standard deviation and mean values within the same graph, when followed by different letters (a,b,
ab), they are signiﬁcantly different at p < 0.05.

TABLE 1 | The N-glycan compositions released from bovine LPO by EndoBI-1.
N-glycan composition
H5N1
H3N3
H6N1
H4N3
H7N1
H5N3
H3N5
H4N3S1
H5N3S1
H4N4S1
H3N5S1

Theoretical m/z

Error (Da)

1151.399
1233.451
1313.450
1395.505
1475.505
1557.564
1639.621
1686.583
1848.651
1889.679
1930.689

1151.400
1233.453
1313.452
1395.506
1475.505
1557.558
1639.611
1686.601
1848.654
1889.680
1930.707

0.001
0.002
0.002
0.000
0.000
-0.006
-0.010
0.018
0.003
0.001
0.018

error of nonlinear calculation. According to the analysis
results, Km values (3.51 ± 0.02, 6.16 ± 0.12, 3.18 ± 0.13, 2.69 ±
0.09, and 3.58 ± 0.02 mg/ml) and Vmax values (6.87, 6.36, 2.09,
2.84, and 4.09 μg/mLxmin) were determined for the free form of
EndoBI-1, and the immobilized enzyme forms including
adsorption and entrapment-based alginate immobilization,
SulfoLink-, and AminoLink-based covalent bonding
immobilization, respectively.
The Vmax value from kinetic characterization analysis and
the activity of free EndoBI-1 were used to estimate the
immobilized enzyme activity. Adsorption on alginate beads
immobilization had the highest activity with the entrapment,
AminoLink-, and SulfoLink-based immobilization methods
retaining 71.55, 20.32, 58.05, and 47.49% activity,
respectively (Figure 4).

FIGURE 4 | Enzyme activity of immobilized EndoBI-1 (adsorption,
entrapment, AminoLink, and SulfoLink) on LPO. Error bars represent standard
deviation and mean values of different groups and are signiﬁcantly different at
p < 0.05.

performed to determine the conditions where the [E] << [S]
condition is fulﬁlled. The concentration of the glycan released
from the protein substrate using constant enzyme concentrations
at different time intervals and different substrate concentrations
were determined. The glycans released from 0.1—0.8 mg/ml LPO
by the free-form enzyme were observed for 50 min at 5-min
intervals, and it was observed that the release of glycan increased
linearly during the ﬁrst 20 min for all concentrations, where the
kinetic studies were carried out by calculating the slope for each
concentration.
The kinetic parameters (Km, Vmax) were calculated using the
linearized Lineweaver–Burk plotting technique to reduce the
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3.3 Characterization of Released N-Glycans
Using Matrix-Assisted Laser
Desorption-Ionization-Time of Flight Mass
Spectrometry
The glycan compositions released from the LPO protein substrate
by different enzyme forms are given in Table 1. In the study,
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FIGURE 5 | MALDI-MS spectra of released N-glycans obtained from free (A), adsorption- (B), entrapment- (C), AminoLink- (D), and SulfoLink-based (E)
immobilized EndoBI-1.

bovine LPO was used as a standard glycoprotein to test the release
of N-glycans using EndoBI-1 enzyme–containing materials. After
the incubation of the samples with free EndoBI-1 enzyme and
EndoBI-1 enzyme–containing materials, the released N-glycans
were labeled with 2-AA, and analyzed by MALDI-MS. Figure 5
shows the MALDI mass spectra belonging to the detected
N-glycans released from different immobilization approaches.

Frontiers in Bioengineering and Biotechnology | www.frontiersin.org

According to the results, it was seen that all the enzymes
immobilized by different immobilization techniques compared
to the enzyme in free form (Figure 5A) could release the same
glycans. These techniques showed different levels of activity in the
enzyme kinetics study. However, when long-term incubation was
provided, all enzyme forms were able to release all N-glycans.
These results also showed that all immobilization techniques
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provide sufﬁcient N-glycan release for the characterization of
N-glycans by MS.

immobilized enzymes with adsorption and the SulfoLink-based
covalent bonding method had low afﬁnity for its substrate
compared to the other forms. Typically, Vmax values were
found to be lower than the free enzyme. Based on these
results, the adsorption on alginate beads immobilization had
the most activity, while the least activity was observed in the
entrapment immobilization method because of EndoBI-1 as a
large substrate molecule that causes transfer problems.
MS analysis showed that all enzymes immobilized by different
immobilization techniques compared to the enzyme in the free
form can release the same types of glycans. These techniques
showed different levels of activity in the enzyme kinetics study.
However, extended incubation time overcame this limitation,
resulting in the release of all N-glycans equivalent to the free form
of the enzyme.
In conclusion, the activity of EndoBI-1, as preserved with all
the immobilization methods tested in this study and with minor
adjustments, and the activity of the immobilized enzymes
matched that of the free form. These ﬁndings highlight that
different immobilization approaches can be used for the effective
enzyme immobilization without any limitations to obtain
bioactive glycans. Thus, further optimization of these
immobilization techniques can be a promising tool for the
future processing scale-up and commercialization of EndoBI-1
and similar enzymes, along with obtaining bioactive glycans for
industrial applications, particularly the food industry.

4 DISCUSSION
Enzymes are specialized catalysts for several chemical reactions and
always play an important role in industrial processes, especially for
food technology. Considering industrial processing, enzymes may
be unsuitable for different applications because of their
characteristic features such as biological origin, activity, and
different conditions including pH and temperature. In such
cases, they have limited stability, and also do not possess an
optimum catalytic feature. Immobilization is an important
strategy to overcome these limitations and improve enzyme
activity, stability, reusability, and speciﬁcities.
In this study, EndoBI-1 enzyme was immobilized with
different types of immobilization strategies including
adsorption, entrapment, and covalent bonding such as
AminoLink- and SulfoLink-based covalent methods. The
protein immobilization yield and the activity of the enzyme
immobilized by each method are investigated. MALDI-TOF
MS analysis was used to characterize the N-glycans released
from LPO using the different immobilized enzyme forms.
The immobilization yield of SulfoLink-, AminoLink-based
covalent bonding, adsorption, and entrapment-immobilized
EndoBI-1 was determined by quantifying the total protein and
remaining unbound protein ﬂuorometrically. Differences between
immobilization yields have been observed because of their
interaction speciﬁcities (hydrophobic interactions and covalent
bonds). High binding efﬁciency was observed in the
AminoLink-based immobilization method followed by
SulfoLink-based immobilization and entrapment immobilization
(4% alginate concentration). However, immobilization with the
adsorption method resulted in the lowest immobilization yield
compared to other immobilization techniques. This is an expected
situation due to the weak binding forces between the enzyme
molecules and the support material. This wear interaction can
cause the leaching of enzymes from the support material, which
hinders the reusability of the enzyme. It was also observed that the
immobilization yield increased by decreasing the acidity level of
sodium acetate solution in the adsorption method. In the
entrapment method, the concentration of alginate beads is the
most important criterion. As expected, the high immobilization
yield was obtained from the high alginate bead concentration.
Considering the kinetic parameters of free and immobilized
EndoBI-1, Km and Vmax values were calculated using the
linearized Lineweaver–Burk plotting technique to reduce the
error of nonlinear calculation. Optimized concentrations and
levels of pH were used for the determination of kinetic
parameters. According to the results, the goodness-of-ﬁt for
the linear regression analysis (R2) for all types of EndoBI-1
forms was found to be ≥ 0.99. Km values for the entrapment
and AminoLink-based immobilization methods were found to be
lower than the free enzyme, whereas high Km values were
obtained after adsorption and SulfoLink-based immobilization
when compared to the free form. Thus, these results showed that
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